ClinVar Miner

Submissions for variant NM_001365951.3(KIF1B):c.3650G>A (p.Arg1217His)

dbSNP: rs1652465916
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001318146 SCV001508837 uncertain significance Charcot-Marie-Tooth disease type 2 2020-09-26 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with KIF1B-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with histidine at codon 1171 of the KIF1B protein (p.Arg1171His). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and histidine.
Ambry Genetics RCV002456426 SCV002616373 uncertain significance Hereditary cancer-predisposing syndrome 2022-01-03 criteria provided, single submitter clinical testing The p.R1171H variant (also known as c.3512G>A), located in coding exon 31 of the KIF1B gene, results from a G to A substitution at nucleotide position 3512. The arginine at codon 1171 is replaced by histidine, an amino acid with highly similar properties. This alteration was detected in a patient with failure to thrive, motor and speech delay, ataxia, dystonia, and spastic paraplegia from a cohort of greater than 2200 Saudi patients who underwent whole exome sequencing (Monies D et al. Am J Hum Genet, 2019 06;104:1182-1201). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Revvity Omics, Revvity RCV003485707 SCV003814571 uncertain significance Charcot-Marie-Tooth disease type 2A1 2019-04-04 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.